Clinical Hepatocellular Carcinoma

The molecular targets of interest have expanded from angiogenesis to cancer cell-directed oncogenic signaling pathways for advanced HCC treatment. The feasibility of combining locoregional therapies and targeted agents, and the use of novel agents after curative treatments are currently under active investigation. Finally, the therapeutic strategy has shifted from monotherapy to combination targeted therapy.

  • Partial Hepatectomy
  • Clinical Analysis of Cells
  • Intra - arterial Chemotherapy
  • AFP Blood Testing

Related Conference of Clinical Hepatocellular Carcinoma

September 23-24, 2019

2nd World Summit on Liver Cirrhosis and Hepatitis

Tokyo, Japan
October 14-15, 2019

19th World Gastroenterologists Summit

Sydney, Australia
October 23-24, 2019

World Congress on Pancreatic Cancer and Liver Diseases

| Tokyo, Japan
November 18-19, 2019

20th World Congress on Gastroenterology

Rome, Italy
December 02-03, 2019

International Conference on Infectious Diseases in Gynecology and Obstetrics

| Radisson Hotel Narita | Tokyo, Japan
June 24-25, 2020

15th Euro-Global Gastroenterology Conference

Rome,Italy

Clinical Hepatocellular Carcinoma Conference Speakers

Recommended Sessions

Related Journals

Are you interested in